- Home
- KLTOW vs OAKU Comparison
KLTOW vs OAKU Comparison
Compare KLTOW & OAKU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLTOW
- OAKU
- Stock Information
- Founded
- KLTOW N/A
- OAKU 2022
- Country
- KLTOW United States
- OAKU Canada
- Employees
- KLTOW 3
- OAKU N/A
- Industry
- KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
- OAKU Blank Checks
- Sector
- KLTOW Health Care
- OAKU Finance
- Exchange
- KLTOW Nasdaq
- OAKU Nasdaq
- Market Cap
- KLTOW N/A
- OAKU N/A
- IPO Year
- KLTOW 2022
- OAKU 2023
- Fundamental
- Price
- KLTOW $0.41
- OAKU $11.75
- Analyst Decision
- KLTOW
- OAKU
- Analyst Count
- KLTOW 0
- OAKU 0
- Target Price
- KLTOW N/A
- OAKU N/A
- AVG Volume (30 Days)
- KLTOW N/A
- OAKU 96.0
- Earning Date
- KLTOW N/A
- OAKU 01-01-0001
- Dividend Yield
- KLTOW N/A
- OAKU N/A
- EPS Growth
- KLTOW N/A
- OAKU N/A
- EPS
- KLTOW N/A
- OAKU 0.03
- Revenue
- KLTOW N/A
- OAKU N/A
- Revenue This Year
- KLTOW N/A
- OAKU N/A
- Revenue Next Year
- KLTOW N/A
- OAKU N/A
- P/E Ratio
- KLTOW N/A
- OAKU $310.78
- Revenue Growth
- KLTOW N/A
- OAKU N/A
- 52 Week Low
- KLTOW N/A
- OAKU $10.83
- 52 Week High
- KLTOW N/A
- OAKU $11.87
- Technical
- Relative Strength Index (RSI)
- KLTOW N/A
- OAKU 74.13
- Support Level
- KLTOW N/A
- OAKU $11.70
- Resistance Level
- KLTOW N/A
- OAKU $11.71
- Average True Range (ATR)
- KLTOW 0.00
- OAKU 0.00
- MACD
- KLTOW 0.00
- OAKU -0.00
- Stochastic Oscillator
- KLTOW 0.00
- OAKU 0.00
About KLTOW Klotho Neurosciences Inc. Warrant
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.